Fetal, Preterm, and Term Neonate Exposure to Remifentanil: A Systematic Review of Efficacy and Safety

CONCLUSIONS: Remifentanil appears to be effective and safe in the short term in preterm and full-term neonates. However, its safety is compromised by the risk of chest wall rigidity. It should be used in appropriate neonatal units and in the presence of physicians able to monitor its side effects. Long-term outcomes have not been evaluated, to our knowledge.PMID:37541994 | DOI:10.1007/s40272-023-00583-w

Source: Paediatric Drugs - August 4, 2023 Category: Pediatrics Authors: Arielle Maroni Marie-St éphanie Aubelle Cl ément Chollat Source Type: research